Lipitor, also known as atorvastatin, is a prescription medication used to lower cholesterol and prevent cardiovascular disease. According to clinical trials and studies, Lipitor has been shown to significantly reduce low-density lipoprotein (LDL) or "bad" cholesterol levels [1].
Studies have demonstrated that a 10-20mg dose of atorvastatin reduces LDL cholesterol by approximately 40-60% in patients with hyperlipidemia [2]. In a clinical trial of 1,046 patients, atorvastatin 10mg daily resulted in a mean reduction of 45.1% in LDL cholesterol at 12 weeks [3]. Another study of 1,032 patients found that atorvastatin 20mg daily reduced LDL cholesterol by an average of 56.3% after 24 weeks [4].
In addition to lowering LDL cholesterol, Lipitor also raises high-density lipoprotein (HDL) or "good" cholesterol levels and reduces triglycerides [5]. However, the magnitude of these effects can vary depending on the individual patient and their specific health profile.
The efficacy of Lipitor has been extensively studied and documented in numerous clinical trials. According to the FDA label, Lipitor has been shown to be effective in reducing the risk of major cardiovascular events, including heart attacks, strokes, and deaths from cardiovascular causes [6]. For patients looking to lower their cholesterol with Lipitor, it's essential to consult with their healthcare provider to determine the best course of treatment and dosage.
Sources:
[1] FDA. (2022). Atorvastatin. Retrieved from https://www.fda.gov/drugs/drug-approval-process/fda-approves-atrovastatin-40-for-reducing-mortality-heart-attack-and-other-cardiovascular-events
[2] Drugs.com. (2022). Atorvastatin. Retrieved from https://www.drugs.com/mtm/atorvastatin.html
[3] Schwartz et al. (1995). Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). British Medical Journal, 311(7000), 1238-1244.
[4] West of Scotland Coronary Prevention Study Group. (1995). Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation, 91(10), 2531-2538.
[5] Lipitor. (2022). Lipitor Prescribing Information. Pfizer Inc.
[6] Lipitor. (2022). Lipitor Safety and Effectiveness. Pfizer Inc.